Preferential survival of an MBP-specific T cell clone in an HLA-DR2 multiple sclerosis patient

T Démoulins1, L Naccache, P Clayette

  • 1Service de Neurovirologie, CEA, CRSSA, EPHE, Fontenay-aux-Roses, France.

Neuroimmunomodulation
|September 11, 2002
PubMed